Trials / Unknown

UnknownNCT04422379

COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study

Status: Unknown
Phase: —
Study type: Observational
Enrollment: 314 (estimated)

Sponsor: Max Healthcare Insititute Limited · Academic / Other
Sex: All
Age: 18 Years – 75 Years
Healthy volunteers: Not accepted

Summary

Detailed description

COVID-19 and liver injury in patients with or without underlying liver disease: A multi-centre retrospective-prospective observational study. All patients infected with SARS-CoV-2 and admitted to the COVID-19 ward/ICU of Max Hospital Saket (either in East Wing , Max Super Specialty Hospital, Saket or MAX Smart Super Specialty Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective data between 1/4/2020- 30/5/2020 \& prospective data from approval till 30/6/2020), will be included Primary objectives 1. To study the prevalence of liver live injury \& factors associated with among patients in-fected with SARS-CoV-2. 2. To study the prevalence of new liver injury and factors associated with it, among patient with underlying liver disease who develops COVD-19. Secondary objectives 1. To correlate the presence and degree of liver dysfunction with the clinical outcomes in these patients. 2. To define the incidence of development of acute liver failure among these patients

Conditions

COVID-19

Timeline

Start date: 2020-06-07
Primary completion: 2020-07-30
Completion: 2020-08-30
First posted: 2020-06-09
Last updated: 2020-06-09

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04422379. Inclusion in this directory is not an endorsement.